Status:

COMPLETED

Perioperative Personalized Blood Pressure Management: IMPROVE-multi

Lead Sponsor:

Universitätsklinikum Hamburg-Eppendorf

Collaborating Sponsors:

Jena University Hospital

The Cleveland Clinic

Conditions:

Blood Pressure

Intraoperative Hypotension

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Rates of major complications and mortality in the first weeks after surgery remain very high: postoperative mortality is still around 2% in central Europe and the United States. Postoperative deaths a...

Eligibility Criteria

Inclusion

  • Consenting patients ≥45 years scheduled for elective major abdominal surgery under general anesthesia that is expected to last ≥90 minutes AND
  • Presence of ≥1 of the following high-risk criteria:
  • exercise tolerance \<4 metabolic equivalents as defined by the guidelines of the American College of Cardiology/American Heart Association
  • renal impairment (serum creatinine ≥1.3 mg/dL or estimated glomerular filtration rate \<90 mL/min/1.73 m2 within the last 6 months)
  • coronary artery disease (any stage)
  • chronic heart failure (New York Heart Association Functional Classification ≥II)
  • valvular heart disease (moderate or severe)
  • history of stroke
  • peripheral arterial occlusive disease (any stage)
  • chronic obstructive pulmonary disease (any stage) or pulmonary fibrosis (any stage)
  • diabetes mellitus requiring oral hypoglycemic agent or insulin
  • immunodeficiency due to a disease (e.g., HIV, leukemia, multiple myeloma, solid organ cancer) or therapy (e.g., immunosuppressants, chemotherapy, radiation, steroids \[above Cushing threshold\])
  • liver cirrhosis (any Child-Pugh class)
  • body mass index ≥30 kg/m2
  • current smoking or 15 pack-year history of smoking
  • age ≥65 years
  • expected anesthesia duration \>180 minutes
  • B-type natriuretic peptide (BNP) \>80 ng/L or N-terminal B-type natriuretic peptide (NT-proBNP) \>200 ng/L within the last 6 months

Exclusion

  • emergency surgery
  • surgery: nephrectomy, liver or kidney transplantation
  • status post transplantation of kidney, liver, heart, or lung
  • sepsis (according to current Sepsis-3 definition)
  • American Society of Anesthesiologists physical status classification V or VI
  • pregnancy
  • patients on renal replacement therapy
  • impossibility of preoperative automated blood pressure monitoring

Key Trial Info

Start Date :

February 26 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 25 2024

Estimated Enrollment :

1272 Patients enrolled

Trial Details

Trial ID

NCT05416944

Start Date

February 26 2023

End Date

July 25 2024

Last Update

December 11 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf

Hamburg, Germany, 20246